Professor Anthony Wierzbicki

Chemical pathology

  • is not fee assuredNot Fee assured

This healthcare professional is currently treating patients. Please speak to them to find out more about their availability.

Last updated: 12 Nov 2020

Specialises in

  • Metabolic medicine

About me

Professor Anthony Wierzbicki is consultant in metabolic medicine/chemical pathology at Guy’s & St. Thomas’ Hospitals and honorary Professor in Cardiometabolic Disease at King’s College London.

His research interests are in the relationship of lipids to atherosclerosis and the role of lipids in peroxisomal diseases. He has been awarded Fellowships of the American Heart Association and of the National Academy of Clinical Biochemistry (USA) for his contributions to atherosclerosis and lipid biology which include 300 publications, 19 book chapters and 1 book.

He was a trustee of HEART-UK (the Cholesterol charity) and was chairman of this charity’s medical and scientific committee. For NICE he has served on technology (2006-9), highly specialised therapies (2013-) and diagnostic appraisal committees (2014-), the Familial Hypercholesterolaemia guideline development group (CG71; 2008-2009) and as chair of the Lipid Modification Guideline Development Group (CG181; 2012-4). He was a writing group member for the International guidelines (2013-14) and the American Heart Association scientific consensus statement on Familial Hypercholesterolemia (2015).

Areas of interest

Hyperlipidaemia; Metabolic medicine; Obesity

Medical secretaries

About me
My outcomes
My qualifications & training
My private practice
Consultant's practices
Report this page Edit details

The information contained on Finder is submitted by consultants, therapists and healthcare services, and is declared by these third parties to be correct and compliant with the standards and codes of conduct specified by their relevant regulatory body. Bupa cannot guarantee the accuracy of all of the information provided.

You can find out more about the information on Finder and our website terms of use.